Delivery Order SPE2DB22D3016-SPE2DB24FBAD8

Award Date 7/5/24
Potential Completion Date 7/26/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,249.49, is for the delivery of Afinitor Disperz 5 mg tablets. The contract is not set aside and is a firm fixed-price delivery order. It has an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $35,747.88, to provide AFINITOR DISPERZ 3 MG TABLET 28S. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Afinitor Disperz 5 mg tablets, a pharmaceutical product, with a ceiling value of $37,000.59. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit organization...
This is a $12,352.52 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AFINITOR 5 MG TABLET UD 28S, a prescription medication, with a period of performance through June 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Afinitor Disperz 2 mg tablets. The contract was awarded on August 5, 2024, with a ceiling value of $20,106.78 and an ultimate completion date of August 26, 2024. This appears to be a firm fixed-price contract for the delivery of pharmaceutical products. The contract is not set aside for any specific business category. Amerisourcebergen is...
This federal contract award is for the delivery of Everolimus 7.5 mg tablets to the Defense Logistics Agency (DLA). The $2,262.85 fixed-price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a completion date of November 22, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a $3,311.50 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of Esbriet 801 mg tablets and has a period of performance through July 29, 2024. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, has awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,785.29, has an ultimate completion date of January 6, 2025. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,841.49, is a delivery order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award IDC, worth up to $999,999,999.00 through December 31, 2025, serves as the primary...
This federal contract award, valued at $57,418.40, was issued by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBAD8
    Delivery Order

This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Afinitor Disperz 3 mg tablets to the Defense Logistics Agency (DLA). The $20,344.14 contract is a Delivery Order under DLA's existing Indefinite Delivery Contract (IDC) with Amerisourcebergen, valued up to $999,999,999 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. As a key pharmaceutical supplier to the federal government, Amerisourcebergen leverages its extensive distribution network to efficiently fulfill critical medical product requirements for the U.S. military and other government agencies.

Generated 10/4/24, 9:17 AM